Helv. Chim. Acta 2021, 104, e2100095
of DNA Binding Specificity of TAL-Type III Effectors’, Science
Author Contribution Statement
2009, 326, 1509–1512.
[15] M. J. Moscou, A. J. Bogdanove, ‘A Simple Cipher Governs
DNA Recognition by TAL Effectors’, Science 2009, 326,
1501.
M. B. performed the experiments. U. S. and E. K.
cultivated HeLa cells and enriched SP1. M. B. and M. W.
G. participated in writing the manuscript.
[16] R. Morbitzer, P. Römer, J. Boch, T. Lahaye, ‘Regulation of
selected genome loci using de novo-engineered tran-
scription activator-like effector (TALE)-type transcription
factors’, Proc. Natl. Acad. Sci. USA 2010, 107, 21617–21622.
[17] M. Jinek, K. Chylinski, I. Fonfara, M. Hauer, J. A. Doudna, E.
Charpentier, ‘A Programmable Dual-RNA–Guided DNA
Endonuclease in Adaptive Bacterial Immunity’, Science
2012, 337, 816–821.
[18] A. W. Cheng, H. Wang, H. Yang, L. Shi, Y. Katz, T. W.
Theunissen, S. Rangarajan, C. S. Shivalila, D. B. Dadon, R.
Jaenisch, ‘Multiplexed activation of endogenous genes by
CRISPR-on, an RNA-guided transcriptional activator sys-
tem’, Cell Res. 2013, 23, 1163–1171.
[19] A. A. Dominguez, W. A. Lim, L. S. Qi, ‘Beyond editing:
repurposing CRISPR–Cas9 for precision genome regulation
and interrogation’, Nat. Rev. Mol. Cell Biol. 2015, 17, 5–15.
[20] M. Kampmann, ‘CRISPRi and CRISPRa Screens in Mamma-
lian Cells for Precision Biology and Medicine’, ACS Chem.
Biol. 2018, 13, 406–416.
[21] E. A. Heiderscheit, A. Eguchi, M. C. Spurgat, A. Z. Ansari,
‘Reprogramming cell fate with artificial transcription
factors’, FEBS Lett. 2018, 592, 888–900.
[22] N. E. Møllegaard, O. Buchardt, M. Egholm, P. E. Nielsen,
‘Peptide nucleic acid. DNA strand displacement loops as
artificial transcription promoters’, Proc. Natl. Acad. Sci. USA
1994, 91, 3892–3895.
[23] B. Liu, Y. Han, D. R. Corey, T. Kodadek, ‘Toward Synthetic
Transcription Activators: Recruitment of Transcription
Factors to DNA by a PNA-Peptide Chimera’, J. Am. Chem.
Soc. 2002, 124, 1838–1839.
[24] B. Liu, Y. Han, A. Ferdous, D. R. Corey, T. Kodadek, ‘Tran-
scription Activation by a PNA-Peptide Chimera in a
Mammalian Cell Extract’, Chem. Biol. 2003, 10, 909–916.
[25] F. Svinarchuk, I. Nagibneva, D. Chern, S. Ait-Si-Ali, L. L.
Pritchard, P. Robin, C. Malvy, A. Harel-Bellan, ‘Recruitment
of transcription factors to the target site by triplex-forming
oligonucleotides’, Nucleic Acids Res. 1997, 25, 3459–3464.
[26] S. Kuznetsova, S. Ait-Si-Ali, I. Nagibneva, F. Troalen, J.-P.
Le Villain, A. Harel-Bellan, F. Svinarchuk, ‘Gene activation
by triplex-forming oligonucleotide coupled to the activat-
ing domain of protein VP16’, Nucleic Acids Res. 1999, 27,
3995–4000.
References
[1] B. Cuenoud, A. Schepartz, ‘Altered specificity of DNA-
binding proteins with transition metal dimerization do-
mains’, Science 1993, 259, 510–513.
[2] M. Ueno, A. Murakami, K. Makino, T. Morii, ‘Arranging
Quaternary Structure of Peptides by Cyclodextrin–Guest
Inclusion Complex: Sequence-Specific DNA Binding by a
Peptide Dimer with Artificial Dimerization Module’, J. Am.
Chem. Soc. 1993, 115, 12575–12576.
[3] E. Pazos, J. Mosquera, M. E. Vázquez, J. L. Mascareñas, ‘DNA
Recognition by Synthetic Constructs’, ChemBioChem 2011,
12, 1958–1973.
[4] J. Mosquera, A. Jiménez-Balsa, V. I. Dodero, M. E. Vázquez,
J. L. Mascareñas, ‘Stimuli-responsive selection of target
DNA sequences by synthetic bZIP peptides’, Nat. Commun.
2013, 4, 1874.
[5] J. Rodríguez, J. Mosquera, R. García-Fandiño, M. E. Vázquez,
J. L. Mascareñas, ‘A designed DNA binding motif that
recognizes extended sites and spans two adjacent major
grooves’, Chem. Sci. 2016, 7, 3298–3303.
[6] G. A. Bullen, J. H. R. Tucker, A. F. A. Peacock, ‘Exploiting
anthracene photodimerization within peptides: light in-
duced sequence-selective DNA binding’, Chem. Commun.
2015, 51, 8130–8133.
[7] Y. Ruiz García, A. Iyer, D. Van Lysebetten, Y. V. Pabon, B.
Louage, M. Honcharenko, B. G. De Geest, C. I. E. Smith, R.
Strömberg, A. Madder, ‘Sequence-selective DNA recogni-
tion and enhanced cellular up-take by peptide–steroid
conjugates’, Chem. Commun. 2015, 51, 17552–17555.
[8] Y. Ruiz García, Y. V. Pabon-Martinez, C. I.E. Smith, A.
Madder, ‘Specific dsDNA recognition by a mimic of the
DNA binding domain of the c-Myc/Max transcription
factor’, Chem. Commun. 2017, 53, 6653–6656.
[9] S. Boga, D. Bouzada, D. García Peña, M. Vázquez López,
M. E. Vázquez, ‘Sequence-Specific DNA Recognition with
Designed Peptides’, Eur. J. Org. Chem. 2018, 249–261.
[10] K. Roy, A. Mazumder, P. Ghosh, G. Naiya, B. Ghosh, S. Roy,
‘A peptide-based synthetic transcription factor selectively
activates transcription in a mammalian cell’, Chem. Com-
mun. 2018, 54, 1611–1614.
[27] M. K. Ghosh, A. Katyal, V. Brahmachari, R. Chandra, ‘Design
and Structural Analysis of Hairpin-TFO for Transcriptional
Activation of Genes in S. cerevisiae’, J. Biomol. Struct. Dyn.
2002, 20, 265–273.
[28] M. K. Ghosh, A. Katyal, R. Chandra, V. Brahmachari,
‘Targeted activation of transcription In Vivo through hair-
pin-triplex forming oligonucleotide in Saccharomyces cer-
evisiae’, Mol. Cell. Biochem. 2005, 278, 147–155.
[29] H. Torigoe, T. Katayama, Y. Tsukamoto, ‘Triplex Formation-
Based Artificial Transcription Factor to Regulate Target
Gene Expression’, Nucleosides Nucleotides Nucleic Acids
2007, 26, 1463–1466.
[11] R. R. Beerli, B. Dreier, C. F. Barbas III, ‘Positive and negative
regulation of endogenous genes by designed transcription
factors’, Proc. Natl. Acad. Sci. USA 2000, 97, 1495–1500.
[12] T. Sera, ‘Zinc-finger-based artificial transcription factors and
their applications’, Adv. Drug Delivery Rev. 2009, 61, 513–
526.
[13] C. Rathnam, S.-T. D. Chueng, L. Yang, K.-B. Lee, ‘Advanced
Gene Manipulation Methods for Stem Cell Theranostics’,
Theranostics 2017, 7, 2775–2793.
[14] J. Boch, H. Scholze, S. Schornack, A. Landgraf, S. Hahn, S.
Kay, T. Lahaye, A. Nickstadt, U. Bonas, ‘Breaking the Code
[30] D. Stanojevic, R. A. Young, ‘A Highly Potent Artificial
Transcription Factor’, Biochemistry 2002, 41, 7209–7216.
www.helv.wiley.com (8 of 9) e2100095 © 2021 The Authors. Helvetica Chimica Acta Published by Wiley-VHCA AG